Novartis (Germany)

1.1k papers and 27.6k indexed citations i.

About

In recent decades, authors affiliated with Novartis (Germany) have published 1.1k papers, which have received a total of 27.6k indexed citations. Scholars at this organization have produced 176 papers in Epidemiology, 161 papers in Molecular Biology and 153 papers in Pulmonary and Respiratory Medicine on the topics of Influenza Virus Research Studies (78 papers), Chronic Myeloid Leukemia Treatments (63 papers) and Renal Transplantation Outcomes and Treatments (58 papers). Their work is cited by papers focused on Molecular Biology (5.7k citations), Epidemiology (5.0k citations) and Oncology (3.9k citations). Authors at Novartis (Germany) collaborate with scholars in Germany, Switzerland and United States and have published in prestigious journals including New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet. Some of Novartis (Germany)'s most productive authors include Jason Hannon, Daniël Hoyer, Harald Gschaidmeier, Matthias Bräutigam, Michael Bröker, Giuseppe Del Giudice, Rino Rappuoli, Oliver G. Ottmann, Angelika Banzhoff and Nicola Groth.

In The Last Decade

Fields of papers published by authors at Novartis (Germany)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Novartis (Germany) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Novartis (Germany) at the time of their publication.

Countries citing scholars working at Novartis (Germany)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Novartis (Germany). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Novartis (Germany) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Novartis (Germany) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025